Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 1.745
Filtrer
1.
Hinyokika Kiyo ; 70(5): 133-136, 2024 May.
Article de Japonais | MEDLINE | ID: mdl-38966924

RÉSUMÉ

Emphysematous cystitis is a relatively rare form of urinary tract infection. A 72-year-old man with diabetes mellitus and long-term indwelling urethral catheterization was diagnosed with emphysematous cystitis. The clinical findings were resolved by conservatively managing the patient with antibiotics. However, cystoscopy subsequently revealed a yellowish-white soft tissue mass in the bladder, which was unlikely to be a bladder tumor. The mass could not be removed easily and frequently caused urinary catheter obstruction. We successfully removed this mass by performing transurethral resection twice. Through histopathological examination, the mass was identified as necrotic tissue comprising bacteria, fibrin, and suspected bladder mucosa.


Sujet(s)
Cystite , Humains , Cystite/chirurgie , Cystite/imagerie diagnostique , Cystite/étiologie , Mâle , Sujet âgé , Nécrose , Emphysème/imagerie diagnostique , Emphysème/chirurgie , Emphysème/étiologie , Vessie urinaire/chirurgie , Vessie urinaire/imagerie diagnostique , Vessie urinaire/anatomopathologie , Tomodensitométrie
2.
J Craniofac Surg ; 35(5): 1449-1455, 2024.
Article de Anglais | MEDLINE | ID: mdl-38838361

RÉSUMÉ

Facial fractures and their historical link to potential blindness have been well-documented, often attributed to optic canal injuries or retinal vascular occlusion. This dire consequence can result from both direct and indirect ocular trauma, including retrobulbar hemorrhage. Traumatic orbital compression can manifest in various forms, such as hematomas, fractured bone fragments, and emphysema, all posing a significant threat to vision, necessitating immediate intervention. In this study, 9 clinical cases of traumatic orbital compression are presented, each characterized by distinct etiologies. The study delves into traumatic orbital compressive syndromes, underscoring the critical imperative of early recognition and treatment to prevent vision loss. Orbital compression, whether from edema, hematoma, or emphysema, collectively culminates in elevated intraorbital pressure and the potential for optic nerve ischemia. Through the presentation of these 9 clinical cases, the article emphasizes the pressing need for timely intervention in addressing orbital compressive syndromes to avert vision loss. Various surgical techniques are elucidated, highlighting the pivotal role of expeditious medical intervention. This article offers invaluable insights into the diagnosis, management, and outcomes of traumatic orbital compressive syndromes.


Sujet(s)
Maladies de l'orbite , Humains , Mâle , Adulte , Femelle , Adulte d'âge moyen , Maladies de l'orbite/étiologie , Maladies de l'orbite/thérapie , Maladies de l'orbite/chirurgie , Hémorragie rétrobulbaire/étiologie , Fractures orbitaires/chirurgie , Fractures orbitaires/complications , Hématome/étiologie , Résultat thérapeutique , Emphysème/étiologie , Emphysème/thérapie , Oedème/étiologie , Syndrome , Sujet âgé , Tomodensitométrie , Cécité/étiologie , Décompression chirurgicale/méthodes
4.
Ann Surg Oncol ; 31(8): 5055-5063, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38739235

RÉSUMÉ

BACKGROUND: Emphysema is generally considered a poor prognostic factor for patients with nonsmall cell lung cancer; however, whether the poor prognosis is due to highly malignant tumors or emphysema itself remains unclear. This study was designed to determine the prognostic value of emphysema in patients with early-stage nonsmall cell lung cancer. METHODS: A total of 721 patients with clinical stage IA nonsmall cell lung cancer who underwent complete resection between April 2007 and December 2018 were retrospectively analyzed regarding clinicopathological findings and prognosis related to emphysema. RESULTS: The emphysematous and normal lung groups comprised 197 and 524 patients, respectively. Compared with the normal lung group, lymphatic invasion (23.9% vs. 14.1%, P = 0.003), vascular invasion (37.6% vs. 17.2%, P < 0.001), and pleural invasion (18.8% vs. 10.9%, P = 0.006) were observed more frequently in the emphysema group. Additionally, the 5-year overall survival rate was lower (77.1% vs. 91.4%, P < 0.001), and the cumulative incidence of other causes of death was higher in the emphysema group (14.0% vs. 3.50%, P < 0.001). Multivariable Cox regression analysis of overall survival revealed that emphysema (vs. normal lung, hazard ratio 2.02, P = 0.0052), age > 70 years (vs. < 70 years, hazard ratio 4.03, P < 0.001), and SUVmax > 1.8 (vs. ≤ 1.8, hazard ratio 2.20, P = 0.0043) were independent prognostic factors. CONCLUSIONS: Early-stage nonsmall cell lung cancer with emphysema has a tendency for the development of highly malignant tumors. Additionally, emphysema itself may have an impact on poor prognosis.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Pneumonectomie , Emphysème pulmonaire , Humains , Carcinome pulmonaire non à petites cellules/chirurgie , Carcinome pulmonaire non à petites cellules/anatomopathologie , Mâle , Tumeurs du poumon/chirurgie , Tumeurs du poumon/anatomopathologie , Tumeurs du poumon/mortalité , Femelle , Études rétrospectives , Taux de survie , Pronostic , Adulte d'âge moyen , Sujet âgé , Études de suivi , Emphysème pulmonaire/chirurgie , Emphysème pulmonaire/anatomopathologie , Emphysème pulmonaire/complications , Stadification tumorale , Emphysème/chirurgie , Emphysème/anatomopathologie , Emphysème/étiologie , Invasion tumorale
6.
Sci Rep ; 14(1): 8718, 2024 04 15.
Article de Anglais | MEDLINE | ID: mdl-38622275

RÉSUMÉ

Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation, with individual body composition influencing disease severity. Severe emphysema worsens symptoms through hyperinflation, which can be relieved by bronchoscopic lung volume reduction (BLVR). To investigate how body composition, assessed through CT scans, impacts outcomes in emphysema patients undergoing BLVR. Fully automated CT-based body composition analysis (BCA) was performed in patients with end-stage emphysema receiving BLVR with valves. Post-interventional muscle and adipose tissues were quantified, body size-adjusted, and compared to baseline parameters. Between January 2015 and December 2022, 300 patients with severe emphysema underwent endobronchial valve treatment. Significant improvements were seen in outcome parameters, which were defined as changes in pulmonary function, physical performance, and quality of life (QoL) post-treatment. Muscle volume remained stable (1.632 vs. 1.635 for muscle bone adjusted ratio (BAR) at baseline and after 6 months respectively), while bone adjusted adipose tissue volumes, especially total and pericardial adipose tissue, showed significant increase (2.86 vs. 3.00 and 0.16 vs. 0.17, respectively). Moderate to strong correlations between bone adjusted muscle volume and weaker correlations between adipose tissue volumes and outcome parameters (pulmonary function, QoL and physical performance) were observed. Particularly after 6-month, bone adjusted muscle volume changes positively corresponded to improved outcomes (ΔForced expiratory volume in 1 s [FEV1], r = 0.440; ΔInspiratory vital capacity [IVC], r = 0.397; Δ6Minute walking distance [6MWD], r = 0.509 and ΔCOPD assessment test [CAT], r = -0.324; all p < 0.001). Group stratification by bone adjusted muscle volume changes revealed that groups with substantial muscle gain experienced a greater clinical benefit in pulmonary function improvements, QoL and physical performance (ΔFEV1%, 5.5 vs. 39.5; ΔIVC%, 4.3 vs. 28.4; Δ6MWDm, 14 vs. 110; ΔCATpts, -2 vs. -3.5 for groups with ΔMuscle, BAR% < -10 vs. > 10, respectively). BCA results among patients divided by the minimal clinically important difference for forced expiratory volume of the first second (FEV1) showed significant differences in bone-adjusted muscle and intramuscular adipose tissue (IMAT) volumes and their respective changes after 6 months (ΔMuscle, BAR% -5 vs. 3.4 and ΔIMAT, BAR% -0.62 vs. 0.60 for groups with ΔFEV1 ≤ 100 mL vs > 100 mL). Altered body composition, especially increased muscle volume, is associated with functional improvements in BLVR-treated patients.


Sujet(s)
Emphysème , Broncho-pneumopathie chronique obstructive , Emphysème pulmonaire , Humains , Pneumonectomie/méthodes , Qualité de vie , Bronchoscopie/méthodes , Emphysème pulmonaire/imagerie diagnostique , Emphysème pulmonaire/chirurgie , Emphysème pulmonaire/étiologie , Emphysème/étiologie , Volume expiratoire maximal par seconde/physiologie , Composition corporelle , Tomodensitométrie , Résultat thérapeutique
9.
Mil Med ; 189(3-4): e907-e910, 2024 Feb 27.
Article de Anglais | MEDLINE | ID: mdl-37769213

RÉSUMÉ

Combined pulmonary fibrosis and emphysema (CPFE) is a clinical syndrome of upper-zone-predominant emphysema on high-resolution CT and a peripheral and basal-predominant diffuse pulmonary fibrosis. Multiple occupational and inhalational exposures have been associated with CPFE. We describe a U.S. veteran, who developed CPFE after a prolonged, intense exposure to trichloroethylene as an aircraft maintenance worker. We believe that this may be another example of occupational-associated CPFE.


Sujet(s)
Emphysème , Emphysème pulmonaire , Fibrose pulmonaire , Trichloroéthylène , Humains , Fibrose pulmonaire/induit chimiquement , Fibrose pulmonaire/imagerie diagnostique , Trichloroéthylène/toxicité , Emphysème pulmonaire/induit chimiquement , Emphysème pulmonaire/complications , Emphysème/étiologie , Emphysème/complications , Fibrose , Études rétrospectives
10.
Am J Physiol Lung Cell Mol Physiol ; 326(1): L98-L110, 2024 01 01.
Article de Anglais | MEDLINE | ID: mdl-38050687

RÉSUMÉ

miR-146a, a microRNA (miRNA) that regulates inflammatory responses, plays an important role in many inflammatory diseases. Although an in vitro study had suggested that miR-146a is involved in abnormal inflammatory response, being a critical factor in the pathogenesis of chronic obstructive pulmonary disease (COPD), in vivo evidence of its pathogenic role in COPD remains limited. Eight-week-old male B6(FVB)-Mir146tm1.1Bal/J [miR-146a knockout (KO)] and C57BL/6J mice were intratracheally administered elastase and evaluated after 28 days or exposed to cigarette smoke (CS) and evaluated after 5 mo. miR-146a expression was significantly increased in C57BL/6J mouse lungs due to elastase administration (P = 0.027) or CS exposure (P = 0.019) compared with that in the control group. Compared with C57BL/6J mice, elastase-administered miR-146a-KO mice had lower average computed tomography (CT) values (P = 0.017) and increased lung volume-to-weight ratio (P = 0.016), mean linear intercept (P < 0.001), and destructive index (P < 0.001). Moreover, total cell (P = 0.006), macrophage (P = 0.001), neutrophil (P = 0.026), chemokine (C-X-C motif) ligand 2/macrophage inflammatory protein-2 [P = 0.045; in bronchoalveolar lavage fluid (BALF)], cyclooxygenase-2, and matrix metalloproteinase-2 levels were all increased (in the lungs). Following long-term CS exposure, miR-146a-KO mice showed a greater degree of emphysema formation in their lungs and inflammatory response in the BALF and lungs than C57BL/6J mice. Collectively, miR-146a protected against emphysema formation and the associated abnormal inflammatory response in two murine models.NEW & NOTEWORTHY This study demonstrates that miR-146a expression is upregulated in mouse lungs because of elastase- and CS-induced emphysema and that the inflammatory response by elastase or CS is enhanced in the lungs of miR-146a-KO mice than in those of control mice, resulting in the promotion of emphysema. This is the first study to evaluate the protective role of miR-146a in emphysema formation and the associated abnormal inflammatory response in different in vivo models.


Sujet(s)
Emphysème , microARN , Broncho-pneumopathie chronique obstructive , Emphysème pulmonaire , Animaux , Mâle , Souris , Emphysème/étiologie , Inflammation/anatomopathologie , Poumon/métabolisme , Matrix metalloproteinase 2/métabolisme , Souris de lignée C57BL , Souris knockout , microARN/génétique , microARN/métabolisme , Pancreatic elastase/métabolisme , Broncho-pneumopathie chronique obstructive/anatomopathologie , Emphysème pulmonaire/induit chimiquement , Emphysème pulmonaire/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE